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Abstract 
This work aims to assess the efficacy of x-ray quality assurance tests undertaken on fluoroscopy 
units in the UK. Information was gathered on the results of dosimetry and safety tests recommended 
by the reports of the Institute of Physics and Engineering in Medicine, and those additionally 
undertaken by medical physics departments.  The assessment of efficacy considers the frequency 
with which a test result breaches the remedial level or other relevant threshold where applicable. 
The third quartile of those results exceeding the remedial level or threshold is used to estimate the 
severity of such a breach in terms of potential impact on patient dose and image quality.  A risk 
assessment approach is then used to recommend to what degree, if any, the test should be included 
in an on-going test regimen. 
Data was analysed from 468 testing sessions to 336 unique fluoroscopy units throughout the UK.  
Across all tests, the rate with which the remedial level was exceeded varied from 0 – 29.5%, with 
severity ranging from little or none to major degradation to image quality or significant increase on 
population dose. Where possible, the data has also been used to produce representative ranges for 
the results of dosimetric tests.  These could be useful as an up to date comparator for those sites 
considering the purchase of or commissioning new equipment. 
Overall the results indicate a wide range for the efficacy of those tests undertaken at present; this 
can be used to review local test protocols and to inform future changes to national guidance in the 
UK. The results also highlight some tests where measurement technique varies significantly 
throughout the UK, making any valid comparison difficult.  This may indicate a need for further 
guidance on how best to undertake these tests. 
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1. Introduction 
This is the second paper published by the Institute of Physics and Engineering in Medicine’s (IPEM) 
Evidence Based Quality Assurance (QA) Working Party.  The primary aim is to assess the effectiveness 
of various QA tests undertaken on x-ray imaging units in terms of patient and staff safety, with due 
consideration to rates of failure and the consequence of a failure.  Secondary aims are to provide data 
on typical ranges of results to guide commissioning of newly installed units and to support future 
decisions on appropriate tolerances. A detailed discussion of the aims of the working party is given in 
the first paper, ‘IPEM Topical Report: An evidence and risk assessment based analysis of the efficacy 
of tube and generator quality assurance tests on general x-ray units’ by Honey et al [1].    
This paper reviews the results submitted for dosimetry and safety tests on fluoroscopy units, as 
recommended by IPEM report 91 [2] and IPEM report 32 parts I [3], II [4] and VI [5], by working party 
members and colleagues from medical physics departments across the UK. Data for additional tests 
not recommended in the IPEM reports [2-5] was also requested and are reviewed.  The analysis of 
results related to image quality tests forms part of a separate study.   
 
2. Materials and methods 
2.1 Data acquisition 
A template spreadsheet was designed listing the fluoroscopy and fluorography tests contained 
within IPEM reports 91 [2] and 32 parts I [3], II [4] and VI [5], and any additional tests that were 
considered by the working party to have become commonplace since the publication of these 
reports.  
The first part of the pro-forma asked the respondents to indicate how often their department 
undertook each of the listed tests and to provide details, including frequency, of additional tests 
performed. This was designed to be quick and simple to complete to encourage a high submission 
rate.  Collection of the details of testing protocols for departments across the UK is considered useful 
to aid in identifying where UK experts consider deviations from the existing IPEM reports are 
required.   Details of the methodology for each test were requested to ensure that all of the results 
for a single test could be compared across all testing sessions and all fluoroscopy units, with due 
regard for, and necessary corrections made to, the technique used to produce the result. 
The second part of the pro-forma was more detailed, requesting summary test results for as many 
testing sessions to as many different fluoroscopy units as possible, to allow for analysis of intra and 
inter unit variability.  For each fluoroscopy unit, the pro-forma requested information about the unit 
including manufacturer and model, the detector type (image intensifier (II) or flat panel detector 
(FPD)), the equipment category (mobile c-arm, mini c-arm or fixed fluoroscopy unit), year of 
installation and the size of its normal and magnification fields (diameter or diagonal length). 
The pro-forma asked which procedures the unit was primarily used for (options were diagnostic 
cardiac and percutaneous coronary intervention (PCI), electrophysiological and device implantation, 
therapeutic cardiac, general cardiac, vascular, neurology, orthopaedics, theatre, barium procedures, 
iodine contrast procedures, urology, lithotripsy, general).  For each unique testing session the pro-
forma requested the date of the testing, reason for testing (commissioning, routine, fault 
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investigation or other) and the testing equipment used by the medical physics department for the 
dose measurements. The tests pertaining to dosimetry and safety included in the pro-forma and the 
requested test result(s) are summarised in table 1. 
Table 1: Dosimetry and safety tests and the corresponding results requested in the pro-forma  
Fluoroscopy 
Test  Reference Requested result(s) 
Dose rate at entrance surface 
of phantom under automatic 
dose rate control (ADRC) 
IPEM 91, FLU06 Largest % change from baseline AND 
measured dose rates (for varying 
programmes and field sizes) 
Dose rate to the input face of 
the image receptor under 
ADRC 
IPEM 91, FLU07 Largest % change from baseline AND 
measured dose rates (for varying 
programmes and field sizes) 
Dose rate to the input face of 
the image receptor under 
ADRC for a collimated beam 
IPEM 32(II), 1.2.2 Measured dose rate 
Dose rate at entrance surface 
of phantom under ADRC for a 
collimated beam 
Additional Measured dose rate 
kV accuracy IPEM 91, RAD12 % or absolute kV deviation from stated 
Accuracy of KAP meter 
calibration  
BIR report 18 % difference between displayed and 
measured 
Accuracy of Reference air 
KERMA (rate) calibration 
BS EN 60601-2-
54: 2009 
% difference between displayed and 
measured 
Tube leakage IPEM report 107 Highest measured leakage 
Tube filtration  ICRP publication 
33 
Measured filtration 
Fluoroscopy timer accuracy BS EN 60601-2-
54: 2009  
Pass or fail 
Fluoroscopy automatic cut-out 
(10 minutes continuous) 
BS EN 60601-2-
54: 2009  
Pass or fail 
 
Fluorography 
Test Reference Requested result(s) 
Dose per image at the input 
face of the image receptor 
under automatic exposure 
control (AEC) 
IPEM 91, FLG04 Largest % change from baseline AND 
measured dose per image (for varying 
programmes and field sizes) 
Collimated dose per image at 
the input face of the image 
receptor under AEC 
Additional Measured dose per image (for varying 
programmes and field sizes) 
Dose per image at the 
entrance surface of a phantom 
under AEC 
Additional Largest % change from baseline AND 
measured dose per image (for varying 
programmes and field sizes) 
Collimated dose per image at 
the entrance surface of a 
phantom under AEC 
Additional Measured dose per image (for varying 
programmes and field sizes) 
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Note that although the term Automatic Brightness Control (ABC) is used in IPEM reports 91 [2] and 32 
[4,5], this paper will use the term Automatic Dose Rate Control (ADRC) throughout. 
The pro-forma was circulated to the medical physics community via a well-established UK based 
medical physics mailing list (with a membership of over 2600 at the time of circulation).  Data was also 
submitted by members of the Evidence Based QA Working Party. The call for data was left open from 
September to December 2014.  Contributors were asked where possible to send original test results 
rather than results measured after corrections had been made by an engineer.  This is most likely to 
occur at equipment commissioning.  For some units, data was received for multiple years testing of 
the same unit; this data has all been included in the analysis subject to a prior check to ensure that it 
does not skew the analysis. 
Once the data had been acquired, the results were validated.  Obvious outliers were identified (either 
very abnormal results or an above average failure rate in the data submitted by a single centre) which 
could be indicative of a mis-typed result or a test technique incompatible with the pro-forma or very 
different from that of other medical physics departments across the UK.  Outliers were discussed with 
representatives from the sites that sent the data. If the validity of the test technique and recording of 
results was confirmed, the data was retained.  Less than 1% of the data that was submitted was 
rejected. 
2.2 Assessment of test efficacy using risk assessment methodology 
The methodology used for assessing the test efficacy was carried out following the risk assessment 
methodology described in Honey et al [1].  The frequency of exceeding a remedial level was graded 
on a scale of 1 to 5 to give a ‘likelihood rating’ (LR) as described in table 2.  A minimum data size of 50 
was required before a LR was assigned. A severity rating (SR) was assigned based on consideration of 
the effects on image quality, the estimated percentage increase to the population effective dose for 
exposures affected by the fault and the maximum absolute increase to individual patient effective 
dose.  Values were assigned based on the highest score from these 3 categories when applying the 
ranges in table 3. For each test, the third quartile of those results that exceeded remedial level was 
considered when assigning a SR. 
The risk matrix (figure 1) indicates the possible outcome for each test. For a risk matrix category of 
green it is proposed that this test may no longer be needed during routine testing sessions.  For tests 
in the yellow, orange or red categories, it is proposed that these tests are continued, but consideration 
is given to reducing the testing frequency of yellow category tests, maintaining the frequency for 
orange category tests, and increasing the frequency of red category tests (possibly by recommending 
their inclusion in radiographer QA programs).  Alternatively, the results may indicate that current 
remedial levels are inappropriate. 
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Table 2: Definition of Likelihood Rating (LR) 
Likelihood rating Frequency (%) of exceeding a remedial 
level 
1 <2 
2 ≥2 and <5 
3 ≥5 and <10 
4 ≥10 and <15 
5 ≥15% 
 
Table 3: Definition of Severity Rating (SR) 
Severity Rating Effect On Image 
Quality 
% increase on 
Population Dose 
Max.  Increase In Individual 
Patient Dose (mSv) 
1 Little/none <5 0.1 
2 Small, unlikely to 
have much effect 
≥5 and <10 0.1-0.5 
3 Noticeable, but 
clinical IQ likely to 
still be acceptable 
≥10 and <20 0.5-2 
4 Significant 
degradation in 
clinical image 
quality 
≥20 and <40 2-5 
5 Major degradation 
in image quality 
likely to seriously 
affect diagnosis 
≥40 >5 or externally reportable 
incident 
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Figure 1: The risk rating matrix 
 
2.3 Statistical analysis 
For the statistical analysis a linear mixed effect model was employed [6].  It was postulated each result 
was potentially influenced by the ‘testing reason’ – the reason for undertaking the tests (e.g. 
commissioning, routine, fault investigation or other) where this is a relevant factor.  Since many of the 
tests involve a comparison with baseline, the results from commissioning testing sessions would not 
be relevant as these results are used for establishing the baseline.  Further influencing factors include 
the ‘equipment age’ (> 10 years old or < 10 years old), the ‘equipment manufacturer’, the ‘medical 
physics department’ undertaking the tests, the ‘equipment type’ (e.g. mobile fluoroscopy unit, fixed 
fluoroscopy unit etc.) and the ‘detector type’ (II or FPD).  All were considered as fixed effects. Most of 
the analysis was undertaken with the data already separated by detector type (i.e. II or FPD).  For some 
tests, additional analysis was undertaken with all of the data together, with detector type added to 
the list of fixed effects. 
Equipment identification code was included as a random effect and is denoted by (1|ID), where ID is 
an identification number unique to the unit. This was considered necessary as a correlation between 
results for the same piece of equipment returned for testing performed over several years cannot be 
assumed to be independent.  A model was then evaluated for the results of each individual test. The 
square brackets indicate factors not included for the analysis of every test. For example, for some tests 
commissioning results are not relevant and, in these situations, ‘testing reason’ was omitted.  
Likewise, ‘detector type’ was omitted when the test results were already stratified by II and FPD units.  
As per the notation of Winter [6], the model can be written as; 
Green 
Yellow 
Orange 
Red 
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Result ~ [Testing Reason +] Equipment Age + Equipment Manufacturer + Medical Physics Department 
+ Equipment Type [+ Detector Type] + (1|ID)  (1) 
The statistical analysis package ‘R’ (The R Foundation for Statistical computing, version 3.3.3) was used 
to perform this analysis.  Null models were created by removing one of each of the fixed variables in 
turn and comparing against the model using an Analysis of Variance (ANOVA) test.  This returned a p 
value which indicated whether removing a parameter from the model had a statistically significant 
effect on the result.  For the purpose of this work p-values of <0.025 were considered statistically 
significant.  For this analysis, the absolute value of all results was considered as it was known that 
some centres had returned results that included positive and negative values whilst others had 
returned only the absolute value.  A logarithmic transform was applied to all data in order to ensure 
linearity, homoscedasticity and normality. 
It is worth noting that this work does not intend to examine or comment upon differences between 
manufacturers.  Such comparisons could not be undertaken fairly because sample sizes will not be 
equal and nothing is known about how well optimised any unit is.  Nevertheless, it was felt worth 
including manufacturer as a fixed effect to determine if this is an important consideration for 
departments to consider locally. 
 
 
3. Results and discussion 
Data were received from 25 UK based medical physics departments.  Of these, all 25 provided data 
pertaining to test frequencies and 15 contained test data for at least one testing session to one 
fluoroscopy unit. In total data were submitted for 468 testing sessions to 336 unique fluoroscopy 
units as indicated in table 4.  
Table 4: The number of units by detector type and equipment type that sets of data were provided 
for 
Detector type Number of unique units 
Image intensifier 213 
Flat panel detector 121 
Unspecified 2 
Equipment type  
Fixed fluoroscopy units 135 
Mobile c-arms 186 
Mini c-arms 12 
Unspecified 3 
 
For the 468 testing sessions, there were data for at least one of the tests identified in table 1. The 
years of first installation range from 1997 to 2015 with a median of 2008.  Test results for the 
reported data extended from February 2006 to January 2015. 
Whilst the pro-forma asked which procedures each unit was primarily used for, it is noteworthy that 
for 68% of units this question was either not completed or it was indicated that the equipment was 
Page 7 of 34 AUTHOR SUBMITTED MANUSCRIPT - PMB-108621.R2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 A
cc
pt
ed
 M
nu
sc
rip
t
for general use.  It was indicated by some large regional departments that this information was often 
not forthcoming, and it was also commented that often equipment was used for more than one 
primary purpose, particularly in smaller centres that have limited equipment.  The multi-functional 
nature of modern equipment has been made possible by being able to run several different software 
packages on one unit making it suitable for many different applications. 
 
3.1 Fluoroscopy results 
3.1.1 Frequency of testing 
The results pertaining to the frequency with which each test is undertaken by the responding 
medical physics departments are summarised in table 5. 
Table 5: Frequency with which each fluoroscopy test is undertaken by responding medical physics 
departments 
Fluoroscopy Tests Test identifier Never  Commissi
oning 
only 
Annual Biennial 
Dose rate at entrance 
surface of phantom under 
ADRC 
IPEM 91, 
FLU06 
- 1 23 1 
Dose rate to the input face 
of the image receptor under 
ADRC 
IPEM91, 
FLU07 
- - 24 1 
Dose rate to the input face 
of the image receptor under 
ADRC for a collimated beam 
IPEM 32(II), 
1.2.2 
15 - 4 - 
Dose rate at entrance 
surface of phantom under 
ADRC for a collimated beam 
Additional 15 - 3 - 
kV accuracy IPEM 91, 
RAD12 
1 2 19 1 
Accuracy of KAP meter 
calibration 
BIR report 18 - 1 23 1 
Accuracy of Reference air 
KERMA (rate) calibration 
BS EN 60601-
2-54: 2009 
6 3 11 - 
Tube leakage IPEM report 
107 
- 20 3 - 
Tube filtration ICRP 
publication 33 
- 9 14 1 
Fluoroscopy timer accuracy BS EN 60601-
2-54: 2009 
15 4 1 - 
Fluoroscopy automatic cut-
out (10 mins continuous) 
BS EN 60601-
2-54: 2009 
6 10 7 - 
 
 
3.1.2 Entrance Surface Dose Rate (ESDR) and Detector Input Dose Rate (DIDR) under 
ADRC 
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IPEM Reports 91 [2] and 32 part II [4] and Martin et al [7] recommend measuring the ESDR on a 
20cm thick water, or water equivalent, phantom located at the approximate position of the patient.  
18.5cm of polymethacrylate (PMMA) is a good approximation to 20cm of water, though there is a 
dependence on beam quality [7].  The attenuating medium and thickness used by 13 of the 14 
medical physics departments that provided data for this test are shown in table 6.  The remaining 
centre used a 20cm Perspex attenuator at commissioning and a 3.6mm copper attenuator 
positioned at the detector for routine testing to reduce the equipment required for routine testing. 
Table 6: The attenuating mediums and their thicknesses used by the responding medical physics 
departments  
No. of medical 
physics departments 
Thickness 
Medium 15cm 18.5cm 20cm 
PMMA / Perspex 1 3 5 
Water 0 0 4 
 
For DIDR under ADRC, IPEM reports 91 [2] and 32 part II [4] recommend placing a copper attenuator 
at the output of the x-ray tube and making dose rate measurements at the image receptor. 
The IPEM 91 [2] remedial level for both of these tests is baseline ±25% and the suspension level is 
baseline ±50% or greater.  IPEM report 91 [2] has a further remedial level for ESDR of a phantom 
under ADRC as > 50mGy min-1 and a suspension level of > 100mGy min-1 for a standard sized patient 
at the largest available field size.  This is only for fluoroscopy modes, not acquisition.   
 
3.1.2.1 Absolute ESDR values 
ESDR results exceeding the remedial and suspension levels of 50mGy min-1 and 100mGy min-1 
respectively for the largest field size and for a standard sized patient (attenuators in the range of 15 
to 20cm were considered as equivalent) were analysed for 400 testing sessions to 251 unique units.  
As most testing sessions contained data for more than one fluoroscopy program, a total of 1332 
different program combinations were analysed.  There were 2 instances of a dose rate exceeding the 
50mGy min-1 remedial level and these were for two different programs on the same unit.  There 
were no instances of the suspension level being exceeded. 
 
3.1.2.2 Percentage change from baseline 
The results for the analysis of percentage change from baseline for ESDR of a phantom under ADRC 
are given in table 7 and for DIDR under ADRC in table 8 (excluding commissioning as these 
measurements form the baseline data for subsequent analysis), where n is the number of submitted 
data sets in the analysis (i.e. from testing sessions fitting the described criteria) 
 
Table 7: ESDR of phantom under ADRC 
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Analysis n Exceeding 
remedial 
level 
Exceeding 
suspension 
level 
Mean 
result of 
those 
exceeding 
remedial 
3rd quartile 
result of those 
exceeding 
remedial 
Maximum 
deviation 
from 
baseline 
All testing sessions 
on all units 
221 25.8% 8.6% 44.7% 54.5% 104.5% 
Most recent testing 
session on all 
unique units 
142 25.4% 8.5% 47% 56.2% 104.5% 
All testing sessions 
on image 
intensifiers 
128 28.9% 7% 42.3% 48.6% 104.5% 
All testing sessions 
on flat panel 
detectors 
93 21.5% 10.8% 49.3% 57% 90% 
 
Table 8: DIDR of the image receptor under ADRC 
Analysis n Exceeding 
remedial 
level 
Exceeding 
suspension 
level 
Mean 
result of 
those 
exceeding 
remedial 
3rd quartile 
result of those 
exceeding 
remedial 
Maximum 
deviation 
from 
baseline 
All testing sessions 
on all units 
288 29.5% 5.2% 44.5% 42.9% 233.3% 
Most recent testing 
session on all 
unique units 
203 29.1% 5.4% 46.0% 40.5% 233.3% 
All testing sessions 
on image 
intensifiers 
189 34.4% 5.8% 45.6% 43.5% 233.3% 
All testing sessions 
on flat panel 
detectors 
97 20.6% 4.1% 40.7% 36.9% 115.0% 
All testing sessions 
on fixed 
fluoroscopy units 
80 23.8% 2.5% 38.2% 37.5% 115.0% 
All testing sessions 
on interventional 
units 
53 24.5% 3.8% 36.1% 41.5% 72.0% 
All testing sessions 
on mobile c-arm 
units 
147 33.3% 7.5% 49.7% 47.5% 233.3% 
All testing sessions 
on mini c-arms 
6 66.7% 0.0% 37.1% 41.5% 43.8% 
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For all testing sessions to all units, the failure rates for both tests received a LR of 5.  The SR was 
assigned based on the 3rd quartile result.  The analysis considered the absolute value of all results.  It 
was considered that an increase in the dose rate would lead to increased population dose, whereas 
a drop in dose rate could have a detrimental effect on image quality through increased noise and 
reduced low contrast spatial resolution.  For both tests this resulted in a SR of 5.  This gives both 
tests a risk matrix category of red indicating the importance of remaining part of routine testing and 
the continued inclusion of dose rate monitoring as part of radiographer QA. 
For the ESDR of a phantom under ADRC, results were found to be statistically significant related to 
‘equipment manufacturer’ (p<0.01) and ‘medical physics department’ (p<0.01).  There was no 
statistical significance related to ‘equipment age’ (p=0.78), ‘equipment type’ (p=0.51) or ‘detector 
type’ (p=0.84). 
For DIDR there was no statistical difference for ‘equipment age’ (p=0.03), ‘equipment manufacturer’ 
(p=0.08), ‘medical physics department’ (p=0.56), ‘equipment type’ (p=0.56) or ‘detector type’ 
(p=0.70). 
‘Medical physics department’ was found to be a significant factor (p<0.01) for ESDR of a phantom 
under ADRC but not for DIDR (p=0.56).  The data submitted indicates that test methods for DIDR are 
closely aligned across departments [2, 4] but less so for ESDR.  Further guidance on ESDR testing, 
including a proposed standardisation of technique, would be welcome. 
 
Whilst both tests demonstrate high fail rates, it is not thought to be completely indicative of 
performance fault condition.  It is known that manufacturers’ representatives make adjustments to 
fluoroscopy units as new software and processing is developed, or in response to user requests. 
Some units also allow users to make adjustments to programmes.    Where the difference in dose 
rate is the result of an intentional and approved change to the unit it is not appropriate to compare 
the result to a previous baseline.  For ESDR of a phantom under ADRC, statistical significance was 
found between manufacturers, which could indicate that the equipment fails this test more often for 
some manufacturers or that some manufacturers undertake these on-going adjustments more often 
than others.  The significance found between medical physics departments could reflect the relative 
distribution of these manufacturers in their reported data. 
The data submitted to the working party cannot distinguish between intentional and unintentional 
changes to dose rate. Following discussion with representatives from medical physics departments 
that submitted data it was noted that the Medical Physics Expert (MPE) is often not informed of 
intentional changes (a particular concern for larger regional medical physics departments where 
there is reliance on the equipment users to pass on information).  The representatives of the medical 
physics departments that submitted data were of the opinion that whilst a breach of remedial level 
would trigger an investigation in which intentional changes would be identified, changes to dose rate 
would not be automatically requested because of the result. Little guidance is given in the literature 
regarding when it is appropriate to set new baselines, or indeed when a unit is no longer acceptable 
for clinical use and it is left as a task for the MPE in collaboration with the users to make these 
decisions. 
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A possible solution would be to only apply remedial levels in the form of percentage change from 
baseline to dose rates measured using a dedicated medical physics or QA program, or a user quality 
control mode as described in NEMA XR-27 [8].  Typically, these programs are set up by the 
manufacturer during commissioning and are stored such that they will be unaffected by future 
adjustments to clinical imaging programs.  These programs are only used during QA testing and offer 
a true comparison against baseline. 
It is still necessary to measure the dose rate for a representative sample of regularly used clinical 
programmes during QA testing to ensure that significant changes are detected and investigated, 
however it is not useful to apply remedial levels in the form of percentage change from the baseline.  
For clinical programmes, and for all programmes on units where an unchanging QA program is not 
an option, representative dose rate ranges might be more useful (discussed in section 3.1.5).  The 
MPE should be involved in considering whether the measured dose rates are appropriate. 
It is possible that intentional reductions in dose rate following improvements to image processing 
will not affect the image quality.  The working party is unable to differentiate between results 
exceeding the remedial level that are the result of intentional changes to the unit or not.  The SR of 5 
is assigned in the knowledge that the 3rd quartile result of those exceeding the remedial level could 
have had little or no effect, but to account for the possibility that it did.  In either case, the ESDR and 
DIDR needs to be routinely tested so changes can be found and investigated. 
 
3.1.3 Variation with dose rate setting 
Fluoroscopy equipment is provided with two or more [9] dose modes (typically low, normal and 
high) for each program to allow the operator to make adjustments in relation to dose rate and the 
required level of image quality.  Martin et al [7] undertook an evidence based exercise in 1997 on 80 
II units to evaluate the effect of varying dose settings on the ESDR of a phantom.  The 2002 edition 
of the MDGN [10] used their results to recommend that for a 20 – 30cm field size and 20cm of water 
equivalent attenuator the low dose mode should result in an ESDR less than 50% that of the normal 
setting, and the high dose setting should result in an ESDR greater than 150% of the normal setting.  
The IEC standards require that for interventional equipment, low and normal dose modes should be 
supplied such that the low dose mode provides an ESDR that is 50% of the normal dose rate setting, 
measured at the patient entrance reference point (PERP, formerly the interventional reference point 
(IRP)) [9,11].  It should be noted that this variation does not directly translate to DIDR as the effects 
on ESDR can be partly achieved through changes to beam quality.  
The data submitted allowed for a review of this relationship.  The analysis was restricted to the most 
recent test results for each unique unit for ESDR with an attenuator thickness in the range of 18.5 – 
20cm.  The results for low to normal dose and normal to high dose for all units are shown in tables 9 
and 10. 
 
Table 9: The ratio of ESDR measured for Low and Normal dose settings for all units by field size 
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Field size (cm) <20 20 – 
30 
>30 
No. Unique units with field size 55 128 61 
Minimum Low – Normal ratio 0.32 0.24 0.22 
1st quartile Low – Normal ratio 0.43 0.46 0.46 
Median Low – Normal ratio 0.51 0.61 0.52 
Average Low – Normal ratio 0.57 0.61 0.59 
3rd quartile Low – Normal ratio 0.67 0.70 0.78 
Maximum Low – Normal ratio 1.07 1.39 0.99 
 
Table 10: The ratio of ESDR measured for High and Normal dose settings for all units by field size 
Field size (cm) <20 20 – 
30 
>30 
No. Unique units with field size 16 93 59 
Minimum High - Normal ratio 1.01 0.45 0.58 
1st quartile High – Normal ratio 2.13 1.53 1.35 
Median High – Normal ratio 2.33 1.75 1.48 
Average High – Normal ratio 2.09 1.76 1.59 
3rd quartile High - Normal ratio 2.36 2.11 1.77 
Maximum High - Normal ratio 2.54 2.5 3.39 
 
These results suggest some variation from the ratios suggested by the IEC [9,11] and Martin et al [7]. 
The mean Low – Normal ratio is quite consistent across all field sizes at 0.59, above the < 0.5 
suggested.  The median ratio is close to 0.5 except for the 20-30cm field size.  The mean High – 
Normal ratio did not exhibit the same consistency across field size but was greater than the 1.5 
suggested by the IEC [9,11] and Martin et al [7] for all field sizes.  The median ratio was also above 
1.5 for all but the >30cm field size. 
Comparisons with the ratios in the IEC standard must take into account the measurement 
conditions.  The IEC measurements are specified at the PERP, whereas values derived in this work 
are from ESDR testing.  The IEC standards are intended as a guide to equipment manufacturers for 
the design and construction of the equipment, whereas ratios derived from ESDR measurements are 
more clinically representative.  These can be used by the MPE for optimisation. 
Anomalous results such as the Low setting giving a higher ESDR than Normal (ratios > 1 in table 9) 
and the High setting giving a lower ESDR than Normal (ratios < 1 in table 10) indicate the usefulness 
of this test. The Low setting gave a higher ESDR than Normal in 1.6% (4) of the results analysed, and 
the Higher setting gave a lower ESDR than Normal in 4.8% (8) of results analysed.  Discussion with 
representatives from the sites that reported these failures indicated the causes are related to 
incorrectly set up clinical programs at equipment commissioning or following software upgrade, or 
changes to the clinical programs made throughout the lifetime of the equipment.  Another cause 
reported is a failure to reload user pre-sets properly following equipment maintenance.  Some 
service agents choose to save user pre-sets prior to starting maintenance work and work with 
default settings to prevent accidental changes to user programs.  These must be properly loaded 
back onto the unit at the end of the maintenance work and this process may occasionally fail. 
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3.1.4 Variation with field size 
Data for all the units submitted indicated that they all had a range of field sizes.  Historically for II 
units, it has been necessary for the dose rate to increase with an inversely proportional relationship 
to the area of the selected field size in order to maintain a constant light photon flux at the output 
phosphor.  For FPD units this constraint does not apply.   Instead, the emphasis is on maintaining a 
constant perceived noise level with the changing ratio of display size to irradiated field size (i.e. the 
effective pixel size).  As such, it is still expected that dose rate will increase towards smaller field 
sizes. 
The measured ESDR for all field sizes under continuous fluoroscopy with a normal dose mode and 
18.5 – 20cm attenuator is shown in figure 2 for II units and figure 3 for fixed installations with FPD.   
Data for fixed installations with II is from 13 unique units, data for mobile units with II is from 137 
unique units and data for fixed installations with FPD is from 15 unique units. 
 
Figure 2: ESDR for different field sizes for mobile (blue circles) and fixed installation (red squares) II 
units measured under continuous fluoroscopy with a normal dose mode and 18.5 – 20cm of PMMA 
or Water attenuating medium 
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Figure 3: ESDR at different field sizes for fixed installation FPD units measured under continuous 
fluoroscopy with a normal dose mode and 18.5 – 20cm of PMMA or Water attenuating medium 
 
Figures 2 and 3 demonstrate a large variation in the measured ESDR for the same field size for both 
fixed installations and mobile units and II and FPD units.  Further analysis indicates a level of 
consistency for identical make and model where the dose rates were generally found to agree to 
within 25% for an equivalent attenuator and program.  This is maintained across different medical 
physics departments.  However, there is little agreement across models by the same manufacturer 
or between different manufacturers.  This is shown in figure 4 for mobile II units and in figure 5 for 
fixed FPD units.  For each manufacturer and equivalent model, the mean ESDR from at least 3 
different units for continuous fluoroscopy, normal dose and using a normal/standard/general 
fluoroscopy program is shown. 
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Figure 4: Mean ESDR for different manufacturer and model mobile II units where data received for 
least 3 different units of same manufacturer and model measured using a general fluoroscopy 
programme, normal dose mode, continuous fluoroscopy and 18.5 – 20cm of PMMA or Water 
attenuating medium  
 
Figure 5: Mean ESDR for different manufacturer and model fixed FPD units where data received for 
least 3 different units of same manufacturer and model measured using a general fluoroscopy 
programme, normal dose mode, continuous fluoroscopy and 18.5 – 20cm of PMMA or Water 
attenuating medium 
The clinical program selected was also observed to have an effect.  The analysis can offer no useful 
range of normal values for variation in ESDR with field size.  Local values should be compared against 
the data provided by the manufacturer; therefore it is important that this data is available.  
Comparison between equivalent units from the same manufacturer where the results were acquired 
using similar settings may also be a valid approach for establishing the expected ESDR for those 
units. 
 
3.1.5 Representative dose rate ranges 
Information was requested pertaining to the equipment’s primary use.   For 68% of submissions, the 
field was left blank or indicated general use.  Sub-division of results by confirmed equipment use 
resulted in sample sizes too small (n < 10) to produce reliable representative ranges by clinical 
application.  Sub-division by program name was considered, however there was too great a 
variability in program name with manufacturer and model to be confident that the comparison was 
appropriate. 
3.1.5.1 Entrance surface dose rate 
Representative ranges for ESDR to a phantom under ADRC are presented for fixed fluoroscopy and 
mobile fluoroscopy units in table 11.  The representative ranges are for the largest field size, 
continuous fluoroscopy, 18.5 – 20cm of attenuator and all clinical programs. 
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Table 11: Representative ESDR for fixed II, mobile II and fixed FPD units for 18.5-20cm of 
attenuating medium 
Analysis Dose mode Diagonal 
Field Size 
(cm) 
n Median 
(mGy min-1) 
Range 
(mGy min-1) 
Inter quartile 
range (mGy 
min-1) 
Fixed Image 
Intensifiers 
 
Normal, 
Continuous 
25 - 40 14 6.0 2.0 – 41.2 4.1 - 12.0 
Mobile 
image 
intensifiers 
  
Normal, 
Continuous 
22 - 33 130 8.7 0.8 – 23.7 3.8 - 12.1 
Fixed Flat 
Panel 
Detectors  
Normal, 
Continuous  
20 - 48 53 11.1 1.8 – 34.2 5.3 – 17.9 
 
3.1.5.2 Detector input dose rate 
IPEM Report 32 part II [4] indicates that the air-KERMA rate under ADRC should be in the range of 
0.2 to 1.0 µGy s-1 for 23 or 25cm input field size.  It goes on to state that for the maximum field size 
available the dose rate should not exceed 1.0 µGy s-1 and should never exceed 2.0 µGy s-1.  Jones et 
al [12] indicate that for an II of 30 cm nominal diameter at 30 frames per second, the DIDR should be 
260 nGy s-1 and suggest corrections for pulse rate and field size for both II and FPD. They also note 
that for FPD there is a restriction on the lowest dose rate of 20 to 50nGy per pulse due to levels of 
electronic noise (this may vary with different generations of digital detector) and that the dose floor 
can be lower in the case of II due to lower amounts of electronic noise present.  
Analysis of the DIDR of the image receptor under ADRC was complicated by the different 
measurement techniques employed with sites using a range of solid state and ionisation chambers 
which may or may not include back scattered radiation, different thicknesses of copper, a wide 
range of dose rate modes, anatomical programmes, pulse rates and anti-scatter grid state.  It was 
necessary to group some data together by varying the range of field sizes to maintain sample sizes > 
10 in each category.   
The range of DIDR for all the 3499 measurements submitted (all phantoms, field sizes, pulse rates 
and modes) was 0.009 to 89.6 µGy s-1, with a mean value of 0.87 µGy s-1and an inter-quartile range 
of 0.27 to 0.74 µGy s-1.  The analysis for continuous fluoroscopy (including 25 and 30pulses per 
second (PPS)) and a ‘normal’ dose rate setting as specified by the manufacturer (includes 
terminologies such as normal, 1/1 and standard), low dose rate setting as specified by the 
manufacturer (includes terminologies such as ½ dose, low dose and reduced dose) and high dose 
rate setting as specified by the manufacturer (includes terminologies such as high level fluoroscopy 
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(HLF) and ‘mA Boost’) is given in table 12 and figure 6.  Insufficient data was submitted using 
comparable parameters for fixed II systems to present values.  
 
 
Table 12: Representative DIDR for fixed II, mobile II and fixed FPD for 1.5-2mm Cu attenuating 
medium, using a Continuous dose rate setting (including 25 and 30pps), grid in where the number of 
test results received (n) was ≥10 
Analysis Dose mode Diagonal 
Field Size 
(cm) 
n Median (µGy s-1) Range  
(µGy s-1) 
Inter quartile 
range (µGy s-1) 
 
Mobile 
Image 
Intensifiers 
 
Normal, 
Continuous 
23 11 0.37 0.29-0.68 0.32-0.43 
15 10 0.81 0.43-1.02 0.60-0.90 
Low, 
Continuous 
 
23 27 0.17 0.09-0.36 0.15-0.21 
15 12 0.18 0.16-0.50 0.17-0.31 
High, 
Continuous 
23 11 0.33 0.27-0.98 0.32-0.63 
 
Flat Panel 
Detectors  
Normal, 
Continuous 
17 - 48 26 1.00 0.15-1.72 0.82-1.20 
 Low, 
Continuous 
30-32 12 0.64 0.12-1.94 0.14-0.84 
25 17 0.95 0.24-1.74 0.86-0.99 
20 38 0.56 0.23-2.03 0.50-0.60 
17 26 0.64 0.38-0.77 0.64-0.66 
15 30 0.73 0.43-1.63 0.70-0.79 
12 28 0.79 0.35-0.96 0.77-0.83 
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Figure 6: DIDR for different field sizes using 1.5mm of copper phantom at the x-ray tube, on 
continuous dose rate (25pps and 30pps accepted as continuous) on Normal (or Standard) 
fluoroscopy dose setting for FPD (blue circles) and II (red squares) 
 
3.1.6 Collimated DIDR to the image receptor under ADRC 
IPEM Report 32 part II [4] recommends that when collimating to an area of 7 x 7cm at the detector 
for the largest field size no excessive increase in DIDR should result.  There is no remedial level 
suggested for this test, it is left as a task for the MPE to determine if an increase in dose is excessive.  
To maintain the approach used throughout for assigning a SR, a remedial level of ±25% of the 
measured DIDR for an uncollimated beam was used.  This is in keeping with the remedial levels used 
for all tests involving DIDR. 
Whilst 3 respondents indicated they perform this test routinely and at commissioning, testing data 
was only received from one site.  The analysis is presented in table 13.  
Table 13: Percentage increase in DIDR for a collimated beam relative to an uncollimated beam at the 
largest field size under ADRC 
 
Analysis n Mean 
difference 
3rd 
Quartile 
increase 
Maximum 
increase 
All units 134 4.6% 11.6% 35.5% 
Image intensifier units 111 5.0% 11.6% 31.1% 
Flat panel detector units 23 2.6% 10.3% 35.5% 
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The 3rd quartile result indicates a SR of 3.  Owing to a lack of specified remedial limit in the guidance, 
and that data for this test was submitted from a single site it was considered that a LR was not 
appropriate. 
 
3.1.7 Relationship between changes in ESDR of a phantom and DIDR at the image receptor 
under ADRC 
Table 5 indicates that the majority of respondents test both ESDR and DIDR annually.  There are 
many reasons to test both.  ESDR data is useful for optimisation, and there are published [2,4,5] 
remedial and suspension levels for ESDR that sites can compare against.  DIDR data can provide a 
useful indication of equipment function such as the performance of the ADRC and has a bearing on 
image quality tests.  Both tests can also be undertaken to monitor changes in equipment 
performance over time through comparison to baseline measurements.  The data were evaluated to 
determine if a significant change in one was reflected in the results of the other; if this were the 
case, it might only be necessary to routinely test one and a significant reduction in the testing could 
be possible.  
For the most recent testing session to all units, the percentage variation from baseline measured for 
both the ESDR and DIDR tests was compared directly to see how closely they agreed.  For 105 
unique units, the results are shown in table 14. 
Table 14: The percentage agreement between the measured deviation from baseline for ESDR and 
DIDR tests undertaken during the same instance of testing for all testing sessions to all units 
 % agreement between the measured deviation from baseline of ESDR and 
DIDR 
0 - 5% 5 – 10% 10 – 15% 15 – 20% 20 – 25% 25 – 50% >50% 
No. of unique 
units 
21.9% 
(n=23) 
21.0% 
(n=22) 
8.6% 
(n=9) 
6.7% 
(n=7) 
9.5% 
(n=10) 
24.8% 
(n=26) 
7.6% 
(n=8) 
 
Table 14 shows that 21.9% (23) of the total number of unique units had a percentile variation from 
baseline for DIDR and a percentile variation from baseline for ESDR that agreed with each other to 
within 5%, suggesting an apparent agreement in the change in dose rate from baseline.  Conversely, 
table 14 also shows that 7.6% (8) of the total number of unique units had a percentile variation from 
baseline for DIDR and a percentile variation from baseline for ESDR that were > 50% different to 
each other, suggesting no agreement in the change in measured dose rate from baseline and that an 
acceptable result for one dosimetric quantity with respect to baseline is not indicative of an 
acceptable result for the other. 
51.5% (54) of units demonstrate agreement between the measured deviations from baseline for the 
ESDR and DIDR tests within 15%.  48.5% of units demonstrated a deviation from baseline for the 
ESDR and DIDR tests that disagreed by more than 15%, with a deviation of more than 25% for just 
over 32% of units.  This is likely due to differences in the way the dose is delivered to the detector 
due to different QA setup with different pulse rates, mA and kV curve and spectral filtration. This 
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means that potentially the same DIDR may be delivered in many ways.  The recording of those 
parameters can aid with the detailed analysis of results. 
The data indicates that the measurements of ESDR and DIDR are complementary to each other and 
comparison of the results can indicate which changes have occurred within the unit.  It is important 
that both are retained as part of equipment QA. 
 
3.1.8 kV accuracy 
This test is described in the tube and generator sections of IPEM report 91[2] and report 32 I and II 
[3,4]. It is applicable to fluoroscopy units and can be measured with a suitable meter. The remedial 
level is the greater of nominal ±5% or ±5kV.  The suspension level is the greater of nominal ±10% or 
±10kV. The results are shown in table 15.  Note that errors are given as absolute (kV) where the set 
kV for the test is < 100 and as a percentage where the set kV for the test is ≥ 100. 
Table 15: The results for absolute and percentage deviations between measured and nominal kV 
Analysis n Exceeding 
remedial 
level 
Largest 
error 
Mean 
result of 
those 
exceeding 
remedial 
Third 
quartile 
result of 
those 
exceeding 
remedial 
Exceeding 
suspension 
level 
All testing 
sessions on all 
units 
145 12.4% 10.7kV, 
73% 
7.0kV, 
13.8% 
7.3kV, 
9.3% 
2.1% 
Most recent 
testing session 
on all unique 
units 
76 11.8% 7.1kV, 
73% 
6.2kV, 
20.6% 
6.5kV, 
9.8% 
1.3% 
All testing 
sessions on 
units with 
image 
intensifiers 
69 15.9% 7.1kV, 
9.8% 
6.2kV, 
6.5% 
6.5kV, 
6.8% 
0% 
All testing 
sessions on 
units with flat 
panel detectors 
76 9.2% 10.7kV, 
73% 
9.3kV, 
21% 
10kV, 
23.3% 
4.0% 
All testing 
sessions on 
fixed 
fluoroscopy 
units 
50 2% 5.7% - - 0% 
All testing 
sessions on 
interventional 
units 
39 18% 10.7kV, 
73% 
9.3kV, 
21.0% 
10kV, 
23.3% 
7.7% 
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All testing 
sessions on 
mobile c-arm 
units 
55 18.2% 7.1kV, 
9.8% 
6.12kV, 
6.6% 
6.5kV, 
7.2% 
0% 
All 
commissioning 
testing sessions 
on all units 
33 3% 5.4% - - 0% 
 
Where no result is entered there is insufficient data to make a robust analysis. 
There were no statistically significant results for kV below 100 (‘ test reason’ (p=0.04), ‘ equipment 
age’ (p=0.85), ‘equipment manufacturer’ (p=0.09), ‘medical physics department’ (p=0.63), 
‘equipment type’ (p=0.88) and ‘detector type’ (p=0.43)), nor were there any statistically significant 
results for kV above 100 (‘test reason’ (p=0.96), ‘equipment age’ (p=0.63), ‘equipment manufacturer’ 
(p=0.81), ‘medical physics department’ (p=0.99), ‘equipment type’ (p=0.64) and ‘detector type’ 
(p=0.69)). 
Based on the failure rate this test is given a LR of 4.  A SR of 3 is applied based on the potential effect 
on image quality, especially with respect to image contrast.  This SR is also relevant where the unit is 
capable of providing radiographic imaging such as in the case of mobile II and FPD units. This gives a 
risk matrix category of orange for this test indicating that there is enough evidence to suggest the 
test should remain or be adopted as part of routine testing. 
As the remedial level for kV accuracy of fluoroscopy units is the same for radiographic units a 
comparison with the results from Honey et al [1] is made.  For radiographic units, 6.4% exceeded the 
remedial level for tube potentials exceeding 100kV, and 9.6% of units exceeded the remedial level 
for tube potentials below 100kV.  The failure rate of fluoroscopy units at the remedial level (table 
15) is higher than for radiographic units, however both are in the orange category of the risk matrix.  
The difference may be related to the test methodology.  Measuring kV on a fluoroscopy unit is more 
challenging than on a radiographic unit.  Additional spectral filtration (employed by fluoroscopy units 
to reduce skin dose) such as copper can produce beam qualities outside the calibration conditions of 
kV meter resulting in an increased uncertainty in the measurement.  This is discussed further in the 
NEMA standard [8].  It is for the MPE to consider the accuracy of the kV measurement for any given 
combination of fluoroscopy unit and kV meter. 
 
3.1.9 KERMA Area Product (KAP) meter and reference air KERMA calibration at the PERP 
KAP meter accuracy testing is not indicated in IPEM 91 [2]. For the purpose of this analysis a 
remedial level of ±25% of a correct value was assumed [13, 14].  However, the IEC standards [9,11] 
indicate acceptable performance to be within 35%.  Reference air KERMA calibration accuracy is a 
test not described for fluoroscopy in IPEM 91 [2] or IPEM report 32 part II [4] since reference air 
KERMA was not widely available when either report was published.  It is thought that most sites that 
have included the reference air KERMA calibration in their routine test protocol are working to the 
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same remedial level as adopted for the KAP meter: ±25%. Again, the IEC standards [9,11] indicate 
acceptable performance to be within 35%. 
The results for both KAP and reference air KERMA calibration accuracy are highly dependent upon 
the measurement technique, which calls into question whether a correct value can be agreed upon.  
If the tests are not carried out in accordance with the manufacturer’s protocol for setting up the unit 
the results are unlikely to agree.  This can cause confusion and disagreement over whether the 
meters should be recalibrated.  When interpreting the reported failure rates for KAP and reference 
air KERMA meter testing it is important to bear in mind that some will be the result of poor 
calibration and some the result of a difference in test technique.  There is insufficient information to 
differentiate between the two for the data analysed as part of this work.  The results for KAP meter 
calibration are shown in table 16; the results for reference air KERMA calibration are shown in table 
17. 
Table 16: the results for the accuracy of KAP meter calibration 
Analysis N Exceeding 
remedial 
level 
Largest 
failure 
Mean 
difference 
of those 
passing 
3rd quartile 
result of those 
exceeding 25% 
For all testing sessions on all 
units 
348 10% 55% 12% 38% 
For all testing sessions - 
couch in  
96 17% 55% 15% 40% 
For all testing sessions - 
couch out 
228 7% 51% 11% 42% 
Fixed units (including 
interventional) – couch in 
96 17% 55% 15% 39% 
Fixed units (including 
interventional) – couch out 
43 12% 42% 
 
10% 42% 
Mobile units – couch out 192 6% 51% 7% 41% 
Table 17: the results for the accuracy of reference air KERMA calibration 
 
The overall failure rate of 9.5% for KAP meter calibration indicates a LR of 3.  The SR is 4, as its 
inaccuracy could lead to the failure to see a need for optimisation or the implementation of 
inappropriate optimisation strategies (as identified in the tube and generator work [1]) which can 
Analysis N Exceeding 
remedial 
level 
Largest 
failure 
Mean result 
of those 
exceeding 
remedial 
3rd quartile 
result of those 
exceeding 35% 
All testing sessions on all 
units 
13 23% 99% 65% 84% 
Most recent testing session 
on all unique units 
10 20% 69% 47% 59% 
All commissioning testing 
sessions on all units 
5 40% 99% 84% 92% 
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have a potential effect on population dose.  This gives a risk matrix category of red indicating it 
should remain as part of routine testing.   
The IEC standard [9] indicates that the KAP meter should be accurate to within ±35% without the 
table present.  This is reflected in the results where units tested without the couch in the beam are 
less likely to exceed the remedial level used in this paper and have a lower mean difference.  Mobile 
units, all of which were indicated to be tested without a couch present, had a lower failure rate and 
smaller difference from true.  This may be indicative of confusion as to whether KAP meters should 
be calibrated with the couch in or out for fixed units, with many medical physics departments opting 
for couch in as being more typical of the clinical setup.  The results suggest a need for guidance on 
test technique and for closer collaboration between MPEs and equipment manufacturers on 
calibration. 
It must be taken into consideration that there was limited data for the results of the reference air 
KERMA calibration accuracy test.  This test stands out as one that is regularly performed (13 sites 
indicated that it is performed to some degree, as shown in table 5) yet very little data was 
submitted.  This could be indicative of the level of confidence placed in the results of this test at 
present.  There was insufficient data to assign a LR.  The SR is dependent upon how the reference air 
KERMA indicator is used locally.  Where not used the SR is not applicable and the test does not need 
to be performed for that particular unit.  Other sites may use it as part of a deterministic effect 
patient follow up protocol [15], in which case it is desirable to have an accurate reading.  There is a 
risk to the individual in that a poorly calibrated reference air KERMA could lead to a failure to trigger 
the appropriate patient follow up protocol.  As with KAP meters, there is a need for guidance on test 
technique and for closer collaboration between MPEs and equipment manufacturers on calibration. 
Increased importance of the accuracy of the calibration of the reference air KERMA may be assumed 
if this was to be utilised for equipment QA.  In accordance with the IEC standards [9,11] typical dose 
rates and doses at the PERP are being given in the literature accompanying fluoroscopic units.  
 
3.1.10 Tube leakage 
Whilst tube leakage is not indicated in IPEM 91 [2], it is a recommended test during the critical 
examination of equipment in IPEM Report 107 [16].  The remedial level is 1mGy hr-1 at 1m [17].  The 
analysis for the results that were submitted are shown in table 18. 
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Table 18: the highest absolute values and the percentage of units exceeding the remedial level for 
tube leakage 
Analysis Unique 
tubes 
Exceeding 
remedial level 
Greatest leakage 
measured (mGy 
hr-1 at 1m) 
For all testing sessions on all units 52 0% 0.59 
For commissioning/new tube/other 
testing sessions on all units 
 47 0% 
 
0.59 
For routine testing sessions on all 
units 
5 0% N/A 
 
There were no reported instances of this test having failed.  The LR is 1.  Although there were no 
failures to inform the SR, SR is rated 5 due to the potential to significantly expose a member of staff 
for a prolonged period, or to irradiate members of the public where shielding is designed to 
attenuate scattered radiation only.  This indicates a risk matrix category of orange.  The test needs to 
remain as part of commissioning.  The sample submitted for routine checks was too small to draw 
any conclusions with confidence.  The equivalent test for tube and generator testing [1] had a 0% 
failure rate for 55 responses.  The conclusion was that the test need only be retained for 
commissioning of new units and testing of new x-ray tubes.   
 
3.1.11 Tube filtration 
The ICRP recommend in publication 33 [18] that total filtration in the useful beam for normal 
diagnostic work shall be equivalent to not less than 2.5mm of aluminium equivalent and is echoed in 
the relevant IEC standard [9]. IPEM report 91[2] does not include a test of tube filtration but this test 
is included in the recommended content of a critical examination in IPEM report 107 [16].  It is worth 
noting that many dosemeters return an estimate of half value layer (HVL) and total filtration in terms 
of aluminium equivalent.  It is likely that many sites undertaking this test routinely do so because the 
result is displayed alongside the other information on the dose meter during kV or output tests. In 
all, there were 103 results submitted for x-ray tube filtration.  The breakdown of units for which tube 
filtration results were submitted is shown in table 19. 
Table 19: The types of unit for which results for tube filtration were reported 
 Unit type 
Detector type Fixed fluoroscopy Mobile c-arm Mini c-arm 
Flat panel detector 37 1 1 
Image Intensifier 12 48 4 
Total 49 49 5 
 
Across all 103 testing sessions there were no failures recorded.  This gives the test a LR of 1.  The SR 
is 5 however as a tube filtration of less than 2.5mm aluminium equivalence would result in a 
significant increase in individual and population skin dose.  It would also mean deviating from a 
longstanding ICRP recommendation [18] and a failure to comply with an IEC standard [9].  This 
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indicates a risk matrix category of orange.  The test needs to remain as part of a critical examination, 
but there is no evidence to suggest it needs to form part of routine testing. 
3.1.12 Fluoroscopy timer accuracy and automatic cut-out 
Though not described in IPEM report 91[2] or IPEM report 32 [4, 5], a number of sites verify the 
accuracy of the fluoroscopy timer.  It is important that the MPE understands what the unit is 
displaying in order to give a definitive analysis of the timer accuracy as some units may display a 
fluoroscopy time representing only the time the x-ray beam is on (i.e. taking the pulse rate and 
length into account).  In this instance the measurement may be useful for characterising the unit, 
especially if the way fluoroscopy time is measured can be altered in the software.  The remedial level 
assumed for this work is any deviation between measured and displayed fluoroscopy time that is in 
excess of the uncertainty of the measurement technique. 
Data were received for only 8 testing sessions with no failures recorded and it is therefore not 
possible to assign a LR.  The SR is 1 as it is of very limited impact.  The fluoroscopy timer could be 
used to terminate a Cine run during an examination but it is not thought that an extended 
fluoroscopy time could give a patient any significant overexposure before being manually 
terminated by the operator.   
Fluoroscopy generators meeting the requirements of the IEC standards [9] should be provided with 
an alarm that sounds after a user defined period and not exceeding 5 minutes of cumulative 
fluoroscopy.  The standard [9] also specifies that exposure automatically terminates after 10 minutes 
of continuous fluoroscopy.  10 minutes was chosen as being beyond any likely clinical exposure.  No 
failures in the automatic termination were recorded from the data of 22 testing sessions.  It is 
difficult to suggest a SR; it is not thought that operators are solely reliant upon an auditory alarm to 
alert them to the fluoroscopy time.  The termination after 10 minutes of exposure is intended as a 
safety mechanism in the event of accidental activation of the unit resulting in an extended exposure. 
As the SR is most likely low, this test has a risk matrix category of green; there is no evidence to 
suggest inclusion in a routine test protocol.  The Radiation Protection Adviser (RPA) may specify a 
test of the automatic cut out as part of a critical examination and this test is included in IPEM report 
107 on critical examinations [16]. 
 
3.2 Fluorography results 
IPEM Report 32 (VI) [5] was written at a time when a secondary system was in use for fluorography.  
This may have been spot-film imaging, or latterly a VHS or similar recording system. As such, a 
thorough evaluation of the fluorography side of the unit was required as components were largely 
separate from the fluoroscopic imaging chain. Modern units utilise the same imaging chain for both 
modes, and often fluorography can be considered to be a high dose mode. The term ‘acquisition 
mode’ may be more appropriate due to this mode often being available for the recording of images 
during a procedure, however with the improvements in technology and the decreasing cost of 
computer memory it is commonly possible to record sections of fluoroscopic imaging. The current 
IPEM guidance can therefore be considered significantly out of date and is an important area where 
updated guidance is required.  
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25 medical physics departments provided data relating to the frequency with which they undertake 
each fluorography test. The results are summarised in table 20. 
Table 20: Frequency with which each fluorography test is undertaken by responding medical physics 
departments 
Fluorography Tests Type of 
Test 
Indicated as 
never performed 
Critical 
Exam only 
Annual Biennial 
Dose per image at the 
input face of the image 
receptor under AEC 
FLG04 - - 24 1 
Collimated dose per image 
at the input face of the 
image receptor under AEC 
Additional 20 - 1 - 
Dose per image at the 
entrance surface of a 
phantom under AEC 
Additional 2 2 20 - 
Collimated dose per image 
at the entrance surface of 
a phantom under AEC 
Additional 19 - 2 - 
DIDR acquisition runs Additional - - 2 - 
ESDR acquisition runs Additional - - 2 - 
kV accuracy Additional - - 1 - 
Tube output Additional - - 3 - 
Timer accuracy (for tube 
measurements) 
Additional - - 1 - 
 
Table 20 highlights some interesting points.  One site chooses to duplicate kV testing using both 
fluoroscopy and fluorography. Where the same tube and generator is used this test does not need to 
be duplicated. 
There is a wide variation in the dosimetry metric being tested.  An analysis of the reported test 
methodology and results for dose per image at the input face of the image receptor under AEC and 
the dose per image at the entrance surface of a phantom under AEC shows variations in the 
reported metric including dose per image, total dose and dose rate from an acquisition run.  A 
review of the data suggests the reported metric changes on a unit-to-unit basis in some cases.  This 
could be a necessary change in technique in response to the capabilities of each individual unit, or to 
reflect how the unit is used clinically. 
3.2.1 Dose per image at the entrance surface of a phantom and dose per image at the 
input face of the image receptor under ADRC 
Dose per image at the entrance surface of a phantom under ADRC is not included in IPEM Report 91 
[2] or Report 32 part VI [5], though it is clear from table 20 that most of the medical physics 
departments that submitted data undertake this test routinely.   For those medical physics 
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departments contributing data, the attenuator choice and thickness was as used for ESDR testing 
under fluoroscopy, as summarised in table 6. 
The IPEM 91 [2] remedial level for dose per image at the input face of the image receptor under 
ADRC is a change from baseline of 25% and suspension is a change from baseline of 50% or more.  It 
is anticipated that medical physics departments contributing data for the dose per image at the 
entrance surface of a phantom under ADRC use the same remedial and suspension levels for this 
test and therefore these values were used for estimating the LR. 
The analysis of the results for dose per image at the entrance surface of a phantom under ADRC are 
given in table 21 and for dose per image at the input face of the image receptor under ADRC in table 
22.  Both exclude commissioning measurements as these measurements form the baseline data for 
subsequent analysis. 
 
Table 21: Analysis of the results of dose per image at the entrance surface of phantom under ADRC 
Analysis N Exceeding 
remedial 
level 
Mean 
result of 
those 
exceeding 
remedial 
3rd 
quartile 
result of 
those 
exceeding 
remedial 
Maximum 
deviation 
from 
baseline 
All testing 
sessions on all 
units 
139 29.5% 66.1% 67.2% 308% 
Most recent 
testing session 
on all unique 
units 
73 32.9% 61.5% 61.8% 217% 
All testing 
sessions on all 
image 
intensifiers 
60 36.7% 71.6% 71.1% 217% 
all testing 
sessions on all 
flat panel 
detectors 
79 24.1% 59.7% 60.6% 308% 
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Table 22: Analysis of the results of dose per image to the input face of the image receptor under 
ADRC 
Analysis n Exceeding 
remedial 
level 
Exceeding 
suspension 
level 
Mean 
result of 
those 
exceeding 
remedial 
3rd quartile 
result of 
those 
exceeding 
remedial 
Maximum 
deviation 
from 
baseline 
All testing sessions 
on all units 
234 26.5% 9.4% 22.7% 26.6% 167.2% 
Most recent testing 
session on all 
unique units 
177 28.2% 11.2% 24.3% 27.4% 167.2% 
All testing sessions 
on image 
intensifiers 
145 33.8% 13.8% 27.1% 33.0% 167.2% 
All testing sessions 
on all flat panel 
detectors 
87 14.9% 2.3% 14.8% 20.1% 58% 
All testing sessions 
on all fixed 
fluoroscopy units 
63 12.7% 7.9% 16.3% 19.9% 68.7% 
All testing sessions 
on all interventional 
units 
47 19.1% 0.0% 15.1% 20.3% 45.9% 
All testing sessions 
on all mobile c-arm 
units 
118 36.4% 13.6% 28.5% 33.8% 167.2% 
All testing sessions 
on all mini c-arms 
5 40% 20% - - - 
 
For all testing sessions to all units, the failure rates for both tests received a LR of 5 assuming the 
remedial level is a change from baseline of 25% and the suspension level is a change from baseline 
of 50% or more.  The SR was assigned based on the 3rd quartile result.  It was considered that an 
increase in the dose per image would lead to an increased population dose, whereas a drop in dose 
per image would have a detrimental effect on image quality.  For the dose per image at the entrance 
surface of phantom under ADRC test the SR is 5, for the dose per image to the input face of the 
image receptor under ADRC the SR is 4.  This gives both tests a risk matrix category of red indicating 
the importance of remaining part of routine testing and the continued inclusion of dose per image 
monitoring as part of radiographer QA. 
For dose per image at the entrance surface of phantom under ADRC there were no results found to 
be statistically significant (‘equipment age’ (p=0.40), ‘equipment manufacturer’ (p=0.69), ‘medical 
physics department’ (p=0.04), ‘equipment type’ (0.62) and ‘detector type’ (0.55)).  For dose per 
image to the input face of the image receptor under ADRC there were no results found to be 
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statistically significant (‘equipment age’ (p=0.94), ‘equipment manufacturer’ (p=0.59), ‘equipment 
type’ (p=0.96) or ‘detector type’ (p=0.98)).  For II units a statistically significant difference was found 
for ‘medical physics department’ (p=0.01) but not for FPD units (p=0.03).  This could be related to 
differences in test technique and the larger number of II in the reported data. 
As was the case with fluoroscopy, the high failure rate is not thought to be completely indicative of 
unit performance.  It would seem prudent to only use the ±25% from baseline remedial level on 
units that have a medical physics or QA program set up on them, or a user quality control mode as 
described in NEMA XR-27 [8].  For all other programs s on these units and for units on which an 
unchanging QA program is not an option, representative doses would be more useful as an aid to 
optimisation.  Insufficient consensus on the measurement method and results reported meant that 
sample sizes were too small to recommend representative ranges.  
It is proposed that updated guidance on a relevant, comparative metric and a common technique to 
measure it (especially with regard to the manner in which a unit is permitted to identify the 
exposure factors prior to the acquisition) would be welcome and allow for a future exercise in 
comparing fluorographic exposures with a view to establishing representative ranges.  This data 
would be extremely useful to the MPE when advising on optimisation. 
It is possible that intentional reductions in dose rate following improvements to image processing 
will not affect the image quality.  The working party is unable to differentiate between results 
exceeding the remedial level that are the result of intentional changes to the unit or not.  The SR of 5 
is assigned in the knowledge that the 3rd quartile result of those exceeding the remedial level could 
have had little or no effect, but to account for the possibility that it did.  In either case, the ESDR and 
DIDR needs to be routinely tested so changes can be found and investigated. 
 
 
4. Summary of results 
A summary of the LR, SR, risk outcome and recommendations for each test is shown in table 23. 
 
Table 23: A summary of the LR, SR, risk outcome and recommendations for all of the fluoroscopy and 
fluorography tests discussed throughout 
Fluoroscopy 
Test Reference LR SR Risk 
outcome 
Recommendation Manuscript 
reference 
ESDR at 
phantom 
under ADRC 
IPEM 91, 
FLU06 
5 5 Red Retain in routine 
testing; include 
physics QA 
programme 
3.1.2 
DIDR under 
ADRC 
IPEM 91, 
FLU07 
5 5 Red Retain in routine 
testing; include 
3.1.2 
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41
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47
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55
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57
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physics QA 
programme 
Variation 
with dose 
rate setting 
- - - - Many instances 
of poorly set up 
units observed; 
include in routine 
testing 
3.1.3 
DIDR under 
ADRC for a 
collimated 
beam 
IPEM 
32(II), 1.2.2 
- 3 Yellow – 
orange 
Include at the 
MPE’s discretion 
3.1.6 
ESDR at 
phantom 
under ADRC 
for a 
collimated 
beam 
Additional - - - Include at the 
MPE’s discretion 
n/a 
kV accuracy IPEM 91, 
RAD12 
4 3 Orange Retain in routine 
testing 
3.1.8 
Accuracy of 
KAP meter 
calibration
  
BIR report 
18 
3 4 Red Retain in routine 
testing 
3.1.9 
Accuracy of 
Reference 
air KERMA 
(rate) 
calibration 
BS EN 
60601-2-
54: 2009 
- Dependent 
on use 
Dependent 
on use 
Include at the 
MPE’s discretion 
3.1.9 
Tube 
leakage 
IPEM 
report 107 
1 5 Orange Commissioning 
only 
3.1.10 
Tube 
filtration
  
ICRP 
publication 
33 
1 5 Orange Commissioning 
only 
3.1.11 
Fluoroscopy 
timer 
accuracy 
BS EN 
60601-2-
54: 2009  
- 1 Green Unnecessary as a 
routine test 
3.1.12 
Fluoroscopy 
automatic 
cut-out (10 
minutes 
continuous) 
BS EN 
60601-2-
54: 2009  
- - Green Unnecessary as a 
routine test 
3.1.12 
 
Fluorography 
Dose per 
image at 
the input 
face of the 
image 
receptor 
under AEC 
IPEM 91, 
FLG04 
5 4 Red Retain in routine 
testing; include 
physics QA 
programme 
3.2.1 
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Dose per 
image at 
the 
entrance 
surface of a 
phantom 
under AEC 
Additional 5 5 Red Retain in routine 
testing; include 
physics QA 
programme 
3.2.1 
 
 
5. Conclusions 
The results presented offer a means of assessing the effectiveness of current testing regimes for the 
dosimetric and safety aspects of fluoroscopy and fluorographic units.  The results highlighted 
significant differences between the testing regimes and methodology (in terms of phantoms used 
and metrics reported) employed by different UK based medical physics departments across the UK.  
This creates uncertainties when analysing trends and increases the width of typical ranges 
presented. The data therefore serves to highlight that rapid technological advancement has 
occurred from when the guidance was published and that there has been little consensus on how to 
adapt test methodologies in response.  Despite these difficulties it was still possible to analyse and 
comment upon the efficacy of a range of tests, to present data on representative ranges for specific 
circumstances and to offer a commentary based on the results received that has in part been 
informed by the opinions expressed by a number of MPEs around the UK to provide an evidence 
base for the development of future guidance.   
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